Matteo Bassetti: Una bella soddisfazione aprire pubmed

Una bella soddisfazione aprire pubmed ( la più importante banca dati al mondo per gli articoli scientifici) al lunedì mattina e trovare l’ennesimo prodotto scientifico del gruppo GECOVID.

Dal 30 gennaio ad oggi, sono 19 gli articoli scientifici sulla tematica COVID  prodotti da questo straordinario gruppo di ricerca clinica. 

Voglio ripeterlo: un gruppo eccezionale di cui faccio parte e che ringrazio ogni giorno di coordinare, fatto di infettivologi, rianimatori, igienisti, cardiologi, medici di pronto soccorso, laboratoristi, statistici e molti altri ugualmente importanti.

Questo è il bello della ricerca scientifica. 

————————————————————–

1.  The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm. 

Bassetti M, Vena A, Giacobbe DR.

Eur J Clin Invest. 2020 Mar;50(3):e13209. doi: 10.1111/eci.13209. 

2.  Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). 

Bassetti M, Giacobbe DR, Aliberti S, Barisione E, Centanni S, De Rosa FG, Di Marco F, Gori A, Granata G, Mikulska M, Petrosillo N, Richeldi L, Santus P, Tascini C, Vena A, Viale P, Blasi F; Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).

Clin Microbiol Infect. 2020 Jul;26(7):880-894. doi: 10.1016/j.cmi.2020.04.031

3.  High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients. 

De Maria A, Varese P, Dentone C, Barisione E, Bassetti M.

J Med Virol. 2020 May 8:10.1002/jmv.25995. doi: 10.1002/jmv.25995. 

4.  Distinct phenotypes require distinct respiratory management strategies in severe COVID-19. 

Robba C, Battaglini D, Ball L, Patroniti N, Loconte M, Brunetti I, Vena A, Giacobbe DR, Bassetti M, Rocco PRM, Pelosi P.

Respir Physiol Neurobiol. 2020 Aug;279:103455. doi: 10.1016/j.resp.2020.103455.

5.  A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic. 

Bassetti M, Pelosi P, Robba C, Vena A, Giacobbe DR.

Drugs Context. 2020 May 26;9:2020-5-2. doi: 10.7573/dic.2020-5-2. 

6.  Bloodstream infections in critically ill patients with COVID-19. 

Giacobbe DR, Battaglini D, Ball L, Brunetti I, Bruzzone B, Codda G, Crea F, De Maria A, Dentone C, Di Biagio A, Icardi G, Magnasco L, Marchese A, Mikulska M, Orsi A, Patroniti N, Robba C, Signori A, Taramasso L, Vena A, Pelosi P, Bassetti M.

Eur J Clin Invest. 2020 Jun 14:e13319. doi: 10.1111/eci.13319. 

7.  COVID-19: Some clinical questions after the first 4 months. 

Bassetti M, Ansaldi F, Icardi G, Pelosi P, Robba C, Taramasso L, Trucchi C, Vena A, Giacobbe DR.

Eur J Clin Invest. 2020 Jun 20:e13326. doi: 10.1111/eci.13326.

8.  Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey. 

Tabah A, Ramanan M, Laupland KB, Buetti N, Cortegiani A, Mellinghoff J, Conway Morris A, Camporota L, Zappella N, Elhadi M, Povoa P, Amrein K, Vidal G, Derde L, Bassetti M, Francois G, Ssi Yan Kai N, De Waele JJ; PPE-SAFE contributors.

J Crit Care. 2020 Jun 13;59:70-75. doi: 10.1016/j.jcrc.2020.06.005. 

9.  Systemic fibrinolysis for acute pulmonary embolism complicating acute respiratory distress syndrome in severe COVID-19: a case series. 

Bona RD, Valbusa A, Malfa G, Giacobbe DR, Ameri P, Patroniti N, Robba C, Gilad V, Insorsi A, Bassetti M, Pelosi P, Porto I; GECOVID study group.

Eur Heart J Cardiovasc Pharmacother. 2020 Jul 14:pvaa087. doi: 10.1093/ehjcvp/pvaa087. 

10.  ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population. 

Benetti E, Tita R, Spiga O, Ciolfi A, Birolo G, Bruselles A, Doddato G, Giliberti A, Marconi C, Musacchia F, Pippucci T, Torella A, Trezza A, Valentino F, Baldassarri M, Brusco A, Asselta R, Bruttini M, Furini S, Seri M, Nigro V, Matullo G, Tartaglia M, Mari F; GEN-COVID Multicenter Study, Renieri A, Pinto AM.

Eur J Hum Genet. 2020 Jul 17:1-13. doi: 10.1038/s41431-020-0691-z. 

11.  High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection. 

Taramasso L, Di Biagio A, Mikulska M, Giacobbe DR, Vena A, Dentone C, De Maria A, Delfino E, Berruti M, Russo C, Orsi A, Bruzzone B, Bassetti M.

Eur J Clin Invest. 2020 Jul 23:e13358. doi: 10.1111/eci.13358

12.  A modular framework for the development of targeted Covid-19 blood transcript profiling panels. 

Rinchai D, Syed Ahamed Kabeer B, Toufiq M, Tatari-Calderone Z, Deola S, Brummaier T, Garand M, Branco R, Baldwin N, Alfaki M, Altman MC, Ballestrero A, Bassetti M, Zoppoli G, De Maria A, Tang B, Bedognetti D, Chaussabel D.

J Transl Med. 2020 Jul 31;18(1):291. doi: 10.1186/s12967-020-02456-z.

13.  Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy. 

Vena A, Giacobbe DR, Di Biagio A, Mikulska M, Taramasso L, De Maria A, Ball L, Brunetti I, Loconte M, Patroniti NA, Robba C, Delfino E, Dentone C, Magnasco L, Nicolini L, Toscanini F, Bavastro M, Cerchiaro M, Barisione E, Giacomini M, Mora S, Baldi F, Balletto E, Berruti M, Briano F, Sepulcri C, Dettori S, Labate L, Mirabella M, Portunato F, Pincino R, Russo C, Tutino S, Pelosi P, Bassetti M; GECOVID study group. Clin Microbiol Infect. 2020 Aug 15:S1198-743X(20)30484-5. doi: 10.1016/j.cmi.2020.07.049 

14.  Tocilizumab and steroid treatment in patients with COVID-19 pneumonia. 

Mikulska M, Nicolini LA, Signori A, Di Biagio A, Sepulcri C, Russo C, Dettori S, Berruti M, Sormani MP, Giacobbe DR, Vena A, De Maria A, Dentone C, Taramasso L, Mirabella M, Magnasco L, Mora S, Delfino E, Toscanini F, Balletto E, Alessandrini AI, Baldi F, Briano F, Camera M, Dodi F, Ferrazin A, Labate L, Mazzarello G, Pincino R, Portunato F, Tutino S, Barisione E, Bruzzone B, Orsi A, Schenone E, Rosseti N, Sasso E, Da Rin G, Pelosi P, Beltramini S, Giacomini M, Icardi G, Gratarola A, Bassetti M.

PLoS One. 2020 Aug 20;15(8):e0237831. doi: 10.1371/journal.pone.0237831. 

15.  Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19. 

Battaglini D, Robba C, Caiffa S, Ball L, Brunetti I, Loconte M, Giacobbe DR, Vena A, Patroniti N, Bassetti M, Torres A, Rocco PR, Pelosi P.

Respir Physiol Neurobiol. 2020 Aug 17;282:103529. doi: 10.1016/j.resp.2020.103529. 

16.  Diagnosing COVID-19-associated pulmonary aspergillosis. 

Verweij PE, Gangneux JP, Bassetti M, Brüggemann RJM, Cornely OA, Koehler P, Lass-Flörl C, van de Veerdonk FL, Chakrabarti A, Hoenigl M; European Confederation of Medical Mycology; International Society for Human and Animal Mycology; European Society for Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; ESCMID Study Group for Infections in Critically Ill Patients.

Lancet Microbe. 2020 Jun;1(2):e53-e55. doi: 10.1016/S2666-5247(20)30027-6. 

17.  Reply to: “Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19”. 

Nicolini LA, Mikulska M, Signori A, Di Biagio A, Portunato F, Vena A, Giacomini M, Bassetti M.

Open Forum Infect Dis. 2020 Jul 29;7(8):ofaa321. doi: 10.1093/ofid/ofaa321.

18.  Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors. 

Vena A, Berruti M, Adessi A, Blumetti P, Brignole M, Colognato R, Gaggioli G, Giacobbe DR, Bracci-Laudiero L, Magnasco L, Signori A, Taramasso L, Varelli M, Vendola N, Ball L, Robba C, Battaglini D, Brunetti I, Pelosi P, Bassetti M.

J Clin Med. 2020 Aug 27;9(9):E2780.

19.  Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? 

Di Biagio A, Taramasso L, Dentone C, Vena A, Giacobbe DR, De Maria A, Mikulska M, Bassetti M; GECOVID Working Group.

AIDS. 2020 Oct 1;34(12):1865-1867. doi: 10.1097/QAD.0000000000002630